ArticleMolecular therapy. Oncology2024

Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma.

Safiya Khurshid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.